Annual Accounts Payable
$554.30 K
-$165.70 K-23.01%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual accounts payable is $554.30 thousand, with the most recent change of -$165.70 thousand (-23.01%) on December 31, 2023.
- During the last 3 years, ENTO annual accounts payable has fallen by -$1.00 million (-64.44%).
- ENTO annual accounts payable is now -79.53% below its all-time high of $2.71 million, reached on December 1, 2021.
Performance
ENTO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.21 M
+$200.90 K+9.98%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly accounts payable is $2.21 million, with the most recent change of +$200.90 thousand (+9.98%) on September 1, 2024.
- Over the past year, ENTO quarterly accounts payable has increased by +$1.66 million (+299.59%).
- ENTO quarterly accounts payable is now -87.99% below its all-time high of $18.45 million, reached on September 1, 2021.
Performance
ENTO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ENTO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.0% | +299.6% |
| 3 y3 years | -64.4% | +371.5% |
| 5 y5 years | -74.8% | -18.3% |
ENTO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.5% | at low | -44.2% | +371.5% |
| 5 y | 5-year | -79.5% | at low | -88.0% | +371.5% |
| alltime | all time | -79.5% | +35.4% | -88.0% | +441.0% |
Entero Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.21 M(+10.0%) |
| Jun 2024 | - | $2.01 M(+0.9%) |
| Mar 2024 | - | $2.00 M(+260.2%) |
| Dec 2023 | $554.30 K(-23.0%) | $554.30 K(-4.3%) |
| Sep 2023 | - | $579.30 K(-63.6%) |
| Jun 2023 | - | $1.59 M(+238.7%) |
| Mar 2023 | - | $469.80 K(-34.8%) |
| Dec 2022 | $720.00 K(-73.4%) | - |
| Dec 2022 | - | $720.00 K(-79.9%) |
| Sep 2022 | - | $3.58 M(-9.7%) |
| Jun 2022 | - | $3.97 M(+15.0%) |
| Mar 2022 | - | $3.45 M(+27.4%) |
| Dec 2021 | $2.71 M(+73.7%) | $2.71 M(-85.3%) |
| Sep 2021 | - | $18.45 M(+314.6%) |
| Jun 2021 | - | $4.45 M(+208.9%) |
| Mar 2021 | - | $1.44 M(-7.6%) |
| Dec 2020 | $1.56 M | $1.56 M(+6.7%) |
| Sep 2020 | - | $1.46 M(-8.6%) |
| Jun 2020 | - | $1.60 M(+20.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $1.32 M(-40.4%) |
| Dec 2019 | $2.22 M(+0.7%) | $2.22 M(-18.2%) |
| Sep 2019 | - | $2.71 M(-3.1%) |
| Jun 2019 | - | $2.80 M(-3.1%) |
| Mar 2019 | - | $2.89 M(+31.1%) |
| Dec 2018 | $2.20 M(+40.0%) | $2.20 M(+92.6%) |
| Sep 2018 | - | $1.14 M(-23.2%) |
| Jun 2018 | - | $1.49 M(+7.7%) |
| Mar 2018 | - | $1.38 M(-12.1%) |
| Dec 2017 | $1.57 M(+46.7%) | $1.57 M(+22.1%) |
| Sep 2017 | - | $1.29 M(+66.6%) |
| Jun 2017 | - | $773.00 K(-42.4%) |
| Mar 2017 | - | $1.34 M(+25.1%) |
| Dec 2016 | $1.07 M(+161.9%) | $1.07 M(-27.8%) |
| Sep 2016 | - | $1.49 M(+16.9%) |
| Jun 2016 | - | $1.27 M(+38.6%) |
| Mar 2016 | - | $916.60 K(+123.9%) |
| Dec 2015 | $409.40 K(-50.4%) | $409.40 K |
| Dec 2014 | $825.60 K | - |
FAQ
- What is Entero Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Entero Therapeutics?
- What is Entero Therapeutics annual accounts payable year-on-year change?
- What is Entero Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Entero Therapeutics?
- What is Entero Therapeutics quarterly accounts payable year-on-year change?
What is Entero Therapeutics annual accounts payable?
The current annual accounts payable of ENTO is $554.30 K
What is the all time high annual accounts payable for Entero Therapeutics?
Entero Therapeutics all-time high annual accounts payable is $2.71 M
What is Entero Therapeutics annual accounts payable year-on-year change?
Over the past year, ENTO annual accounts payable has changed by -$165.70 K (-23.01%)
What is Entero Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ENTO is $2.21 M
What is the all time high quarterly accounts payable for Entero Therapeutics?
Entero Therapeutics all-time high quarterly accounts payable is $18.45 M
What is Entero Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ENTO quarterly accounts payable has changed by +$1.66 M (+299.59%)